VR
LABU icon

Valued Retirements’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Valued Retirements’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
+1,555
New +$298K 0.41% 53

Other funds holding LABU

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Valued Retirements's LABU Position: Q2 2026 in Review

Valued Retirements opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 1,555 shares worth $454K. The stake represents 0.41% of the portfolio and ranks #53 among its holdings.

27 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Valued Retirements held 1,555 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $454K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Valued Retirements position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.41% of Valued Retirements's portfolio in Q2 2026, its #53 holding.
  • 27 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Valued Retirements's 13F filing for Q2 2026, filed 13 Aug 2026.